These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CRISPRi functional genomics in bacteria and its application to medical and industrial research. Enright AL; Heelan WJ; Ward RD; Peters JM Microbiol Mol Biol Rev; 2024 Jun; 88(2):e0017022. PubMed ID: 38809084 [TBL] [Abstract][Full Text] [Related]
4. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review). Alagoz M; Kherad N Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995 [TBL] [Abstract][Full Text] [Related]
5. Application of CRISPR/Cas9 technology in sepsis research. Wu M; Hu N; Du X; Wei J Brief Funct Genomics; 2020 May; 19(3):229-234. PubMed ID: 32058568 [TBL] [Abstract][Full Text] [Related]
7. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery. Ahmad G; Amiji M Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075 [TBL] [Abstract][Full Text] [Related]
8. Advances in therapeutic application of CRISPR-Cas9. Sun J; Wang J; Zheng D; Hu X Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 for cancer therapy: Opportunities and challenges. Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591 [TBL] [Abstract][Full Text] [Related]
10. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering. Cho S; Shin J; Cho BK Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180 [TBL] [Abstract][Full Text] [Related]
11. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination. Peng H; Le C; Wu J; Li XF; Zhang H; Le XC ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826 [TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 technology as a potent molecular tool for gene therapy. Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727 [TBL] [Abstract][Full Text] [Related]
13. Nuclease-Deficient Clustered Regularly Interspaced Short Palindromic Repeat-Based Approaches for Lek A; Ma K; Woodman KG; Lek M Hum Gene Ther; 2021 Mar; 32(5-6):260-274. PubMed ID: 33446040 [TBL] [Abstract][Full Text] [Related]
14. Genome-scale CRISPR pooled screens. Sanjana NE Anal Biochem; 2017 Sep; 532():95-99. PubMed ID: 27261176 [TBL] [Abstract][Full Text] [Related]
16. Creating cell and animal models of human disease by genome editing using CRISPR/Cas9. Zarei A; Razban V; Hosseini SE; Tabei SMB J Gene Med; 2019 Apr; 21(4):e3082. PubMed ID: 30786106 [TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas tools to study gene function in cytokinesis. Husser MC; Skaik N; Martin VJJ; Piekny A J Cell Sci; 2021 Apr; 134(8):. PubMed ID: 33912919 [TBL] [Abstract][Full Text] [Related]
18. Genetically Engineering the Nervous System with CRISPR-Cas. Sandoval A; Elahi H; Ploski JE eNeuro; 2020; 7(2):. PubMed ID: 32098761 [TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges. Cheng X; Fan S; Wen C; Du X Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006 [TBL] [Abstract][Full Text] [Related]
20. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges. Pei WD; Zhang Y; Yin TL; Yu Y Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]